AMA 'fact sheet' explains impact of hydrocodone rescheduling
 
The American Medical Association (AMA) has released a ‘fact sheet’ for physicians on the final rule by the U.S. Drug Enforcement Administration that will reschedule hydrocodone combination products into Controlled Substance Schedule II as of October 6. The fact sheet explains how the regulatory change will affect both physicians and pharmacists. Prescriptions issued before October 6 with refills can be dispensed in accordance with current DEA rules, while central filling for Schedule III-V controlled substances can occur until April 8, 2015. However, the AMA cautions that state laws and some pharmacy and insurance processes may deny refill requests after the rule takes effect.

 Link to source (Registration required)>>